Abstract
The review is devoted to the recent publications and patents focusing on drug-eluting stents (DESs), which due to their ability in reducing restenosis are becoming the lead player for the treatment of coronary artery disease (CAD). Various approaches have been used in development of these medical devices. Most DES architecture includes three components: a stent platform, a drug delivery vehicle and therapeutic agent; each part has significant impact on the biological performance of DES. The paper outlines the new developments on drug-eluting stents sustained by patents literature.
Keywords: Bioresorbable, drug-eluting stent, polymer, therapeutic agent.
Related Books
Metal Matrix Composites: A Modern Approach to Manufacturing
Bioderived Materials: Harnessing Nature for Advanced Biochemical Handiwork
Nanoscale Field Effect Transistors: Emerging Applications
Biocarbon Polymer Composites
Manufacturing and Processing of Advanced Materials
Nanoelectronics Devices: Design, Materials, and Applications Part II
Nanoelectronics Devices: Design, Materials, and Applications (Part I)
Green Plant Extract-Based Synthesis of Multifunctional Nanoparticles and their Biological Activities
Industrial Applications of Polymer Composites
Synthesis and Applications of Semiconductor Nanostructures
14